INFLUENCE OF STEROID MEDICATION ON BONE-MINERAL DENSITY IN CHILDREN WITH NEPHROTIC SYNDROME

被引:59
作者
LETTGEN, B
JEKEN, C
REINERS, C
机构
[1] Department of Paediatric, University of Essen, Essen, 45122
[2] Department of Nuclear Medicine, University of Essen, Essen, 45122
关键词
NEPHROTIC SYNDROME; STEROID THERAPY; CYCLOPHOSPHAMIDE; BONE MINERAL DENSITY; PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY;
D O I
10.1007/BF00869084
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Bone mineral density (BMD) was studied in 26 children with idiopathic nephrotic syndrome and in age- and sex-matched healthy controls. BMD was selectively measured in trabecular (TBD), cortical (CBD) and total bone (ED) using peripheral quantitative computed tomography. Patients showed a decrease in ED, CBD and TBD. ED and CBD were inversely correlated with the cumulative dose of steroid treatment, Of the 26 patients with high cumulative doses of steroid, 16 were also treated with cyclophosphamide. In this group ED and CBD were decreased significantly compared with the children with a low cumulative steroid dose only. Compared with controls for each subgroup, significant decreases in ED, CBD and TBD were found in the group with high cumulative doses of steroids only. The higher cumulative steroid dose and the initial steroid toxicity which made cytotoxic therapy necessary, rather than cyclophosphamide itself, may be responsible for these findings.
引用
收藏
页码:667 / 670
页数:4
相关论文
共 24 条
[1]  
Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis, Kidney Int, 13, pp. 159-165, (1978)
[2]  
The primary nephrotic syndrome in children. Identification of patients with minimal-change nephrotic syndrome from initial response to prednisone, J Pediatr, 98, pp. 561-564, (1981)
[3]  
Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children, Lancet, 1, pp. 380-383, (1988)
[4]  
Lam C.N., Arneil G.C., Long-term dwarfing effects of corticosteroid treatment of childhood nephrosis, Arch Dis Child, 43, pp. 589-594, (1968)
[5]  
Rees L., Greene S.A., Adlard P., Joners J., Haycock G.B., Rigden S.P.A., Preece M., Chantler C., Growth and endocrine function in steroid sensitive nephrotic syndrome, Arch Dis Child, 63, pp. 484-490, (1988)
[6]  
Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with twelve week course, Arch Dis Child, 62, pp. 1102-1106, (1987)
[7]  
Barratt T.M., Cameron J.S., Chantler C., Ogg C.S., Soothill J.F., Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood, Arch Dis Child, 48, pp. 286-290, (1973)
[8]  
Dambacher M.A., Ruegsegger P., Nichtinvasive Untersuchungsmethoden bei Osteoporosen, Ther Umsch, 42, pp. 339-350, (1985)
[9]  
Schneider P., Berger P., Moll E., Reiners, Borner W., Knochendichtemessung von Spongiosa und Kompakta mit einem J-125 CT-Scanner: Bestimmung des Mineralgehalts im Radius mit zwei unterschiedlichen Methoden, Radioaktive Isotope in Klinik und Forschung, pp. 731-739, (1986)
[10]  
Lassmann M., Borner W., Die Strahlenexposition bei Knochendichtemessungen, Strahlenexposition bei neuen diagnostischen Verfahren, pp. 51-63, (1993)